Author
Aimilia D. Sklirou
Also Known As
, 153 10 Athens, Greece, A D Sklirou, A Sklirou, Aimilia D Sklirou, Aimilia D. Sklirou, Aimilia Sklirou, Sklirou, Aimilia, Sklirou, Aimilia D., proteasome inhibitors (PIs) have demonstrated clinical efficacy in the treatment of multiple myeloma (MM) and mantle cell lymphoma and are evaluated for the treatment of other malignancies. Herein we analyzed the molecular responses induced in red blood- (RBCs) cells and peripheral blood mononucleated- (PBMCs) cells of MM patients treated with therapeutic PIs; given also that disease relapse usually refers to MM cells that survive therapy
55
Publications
1.5K
Citations
22
H-Index
49
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 8 | 8 | 411 |
2 | Allergy | 2 | 2 | 55 |
3 | Biochemistry | 2 | 2 | 114 |
4 | Biomolecular Engineering | 1 | 1 | 49 |
5 | Cell Biology | 1 | 1 | 65 |
Aimilia D. Sklirou
×
25
Publications
1K
Citations
21
H-Index
| Year | Citations | |
|---|---|---|
Page 1
Page 1